Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"Fibrates"”.

  1. The Role of Fibrates and Soluble Amyloid Precursor Alpha in Alzheimer’s Disease and Longevity

    … therapy for AD. A group of drugs known as fibrates have previously been shown to upregulate ADAM10 through peroxisome proliferator-activated receptor α (PPARα), reducing amyloid plaque load and improving learning and memory in AD mouse models. In the current study we have investigated the …

    lancaster Download PDF for The Role of Fibrates and Soluble Amyloid Precursor Alpha in Alzheimer’s Disease and Longevity (opens in a new tab) Embargoed until 2028-08-31

  2. Assessment of two antilipidemic drug subclasses (fibrates and statins) on embryogenesis in two model fish species (Danio rerio and Pimephales promelas)

    … Nine antilipidemic drugs within two subclasses, fibrates (fenofibrate and gemfibrozil) and statins (atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin) are currently prescribed to humans. Embryogenesis in fish is a critical process in development that …

    colostate Repository record for Assessment of two antilipidemic drug subclasses (fibrates and statins) on embryogenesis in two model fish species (Danio rerio and Pimephales promelas) (opens in a new tab)

  3. BEYOND PEROXISOME: ABCD2 MODIFIES PPARα SIGNALING AND IDENTIFIES A SUBCLASS OF PEROXISOMES IN MOUSE ADIPOSE TISSUE

    … We next evaluated the impact of D2 on effects of fibrates in a mouse model of dietinduced obesity. Fenofibrate treatment opposed the development of obesity, hypertriglyceridemia, and insulin resistance. However, these effects were unaffected by D2 genotype. We concluded that D2 can modulate …

    uky-thes Repository record for BEYOND PEROXISOME: ABCD2 MODIFIES PPARα SIGNALING AND IDENTIFIES A SUBCLASS OF PEROXISOMES IN MOUSE ADIPOSE TISSUE (opens in a new tab)

  4. The significance of sAPPα production to increase cell viability in Alzheimer’s disease cell models

    … models and explore therapies to enhance sAPPα. Fibrates have previously been used to increase sAPPα release and we tested this in the AD-related cell model Swedish mutant APP695 (SweAPP)-SH-SY5Y. However, the fibrates were found to not enhance release of sAPPα via ADAM10 expression. …

    lancaster Download PDF for The significance of sAPPα production to increase cell viability in Alzheimer’s disease cell models (opens in a new tab)

  5. The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species

    Statins and fibrates are the most widely used pharmaceuticals in developed countries for the treatment of hyperlipidemia. They reach the aquatic environment mainly via wastewater treatment plants and have been detected at concentrations of ng to µg/L. They are “pseudopersistent” due to their …

    ottawa-retro Repository record for The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species (opens in a new tab)

  6. Investigation into the mechanism and treatment of atherogenic dyslipidemia in HIV + patients with HIV metabolic syndrome

    … and serum lipids in our cohort. In our cohort fibrates significantly decreased serum triglycerides (37%, p=0.028) while fibrates, in combination with statins significantly decreased serum triglycerides and total cholesterol (52%, p=0.002 and 20%, p=0.007 respectively). There were no significant …

    ubc Repository record for Investigation into the mechanism and treatment of atherogenic dyslipidemia in HIV + patients with HIV metabolic syndrome (opens in a new tab) Download PDF for Investigation into the mechanism and treatment of atherogenic dyslipidemia in HIV + patients with HIV metabolic syndrome (opens in a new tab)

  7. Novel Strategies to Combat Dyslipidemia in Diabetic Retinopathy

    … to treat DR. A combination of Statins and Fibrates significantly slowed the progression of DR over four years in the ACCORD Eye study. The underlying mechanism of how lipid-lowering agents elicit their beneficial effects remains unknown as positive effects on serum lipid levels did not …

    msu Repository record for Novel Strategies to Combat Dyslipidemia in Diabetic Retinopathy (opens in a new tab)

  8. Investigation of Ascites’ Protection of Ovarian Cancer Cells Against Ferroptosis

    … activation of lipid catabolism with fibrates reverses ascites-induced remodeling, restores ferroptosis sensitivity, and reduces peritoneal tumor dissemination in mouse models. Together, these findings establish ascites as an active metabolic regulator that suppresses ferroptosis and …

    duke Repository record for Investigation of Ascites’ Protection of Ovarian Cancer Cells Against Ferroptosis (opens in a new tab)

  9. Pyruvate Dehydrogenase Kinase 4 Deficiency and Hepatic Steatosis

    … mechanism for prevention of hepatic steatosis by fibrates. PDK4 deficiency had no effect on CD36 expression but reduced the enzymatic capacity for fatty acid synthesis, suggesting clofibric acid and PDK4 deficiency ameliorate hepatic steatosis by independent mechanisms. Investigation of the …

    iupui Repository record for Pyruvate Dehydrogenase Kinase 4 Deficiency and Hepatic Steatosis (opens in a new tab)

  10. Human pharmaceuticals in the environment: Effects of fibrate drugs on two fish species

    … drug gemfibrozil (GEM), although the other fibrates bezafibrate (BEZA), clofibrate (CLO) and fenofibrate (FENO) were used for specific experiments. Waterborne GEM exposure resulted in bioconcentration factors up to 500 in goldfish using LC-MS/MS estimates. Results provided strong evidence …

    ottawa-retro Repository record for Human pharmaceuticals in the environment: Effects of fibrate drugs on two fish species (opens in a new tab)

  11. Characterization of Hypertriglyceridemia in Obese Diabetic TallyHo/Jng Mice

    … with pharmacological therapy. Statins, fibrates, niacin, and thiazolidinediones are commonly used to treat dyslipidemia associated with insulin resistance and T2DM.</p> <p>The TALLYHO/Jng (TH) mouse strain is a newly established polygenic inbred model for T2DM that shows obesity, …

    ut-knoxville Repository record for Characterization of Hypertriglyceridemia in Obese Diabetic TallyHo/Jng Mice (opens in a new tab)

  12. Anti-hyperlipidemic activities of Ilex latifolia and other selected herbs

    … drug therapy is required. Statins, fibrates, nicotinic acid bile acid sequestrants, and ezetimibe are approved drugs for the treatment of hyperlipidemia. Because of the tolerability problems, side effects, and low effectiveness of some of these drugs, discovery of new drugs is …

    london-metro Download PDF for Anti-hyperlipidemic activities of Ilex latifolia and other selected herbs (opens in a new tab)

  13. Studies on the Structural and Metabolic Heterogeneity in Low Density Lipoprotein

    … drugs- resins, nicotinic acid derivatives, fibrates and statins. Those drugs which act through the lowering of plasma triglyceride reduced the concentrations of LDL III and those whose mode of action is by activation of the LDL receptor, reduced the concentrations of the larger LDL I and LDL …

    glasgow Download PDF for Studies on the Structural and Metabolic Heterogeneity in Low Density Lipoprotein (opens in a new tab)

  14. Επίδραση υπολιπιδαιμικών φαρμάκων στη μάζα της Lp-PLA2 και σε άλλους δείκτες φλεγμονής σε άτομα με πρωτοπαθή υπερλιπιδαιμία

    … classes of lipid-lowering drugs like statins, fibrates, ezetimibe, bile acid binding resins, nicotinic acid and omega-3 fatty acids. Each of these drugs affects the metabolism of lipids through different ways and exerts various results in the reduction of both the lipoprotein levels and the …

    greece Repository record for Επίδραση υπολιπιδαιμικών φαρμάκων στη μάζα της Lp-PLA2 και σε άλλους δείκτες φλεγμονής σε άτομα με πρωτοπαθή υπερλιπιδαιμία (opens in a new tab)

  15. The Regulation of Triglyceride Metabolism in the Liver and Adipose Tissue

    … inhibitor of HSL. Thiazolidinediones (TZD), fibrates and a beta3 agonist had no inhibitory effects on HSL activity in the isolated rat adipocyte. Studies administering nicotinic acid to Zucker rats were conducted and allowed the in vivo antilipolytic effects of nicotinic acid, primarily on …

    glasgow Download PDF for The Regulation of Triglyceride Metabolism in the Liver and Adipose Tissue (opens in a new tab)

  16. Die effek van besafibraat en 'n oplosbare nie-styselpolisakkariedsupplement op risikofaktore van koronêre hartvatsiekte in primate

    … to dietary recommendations. Among such drugs, fibrates have been widely used for many years. Bezafibrate (BF) , one of the newer derivates of clofibrate, is a well-tolerated drug with potent hypolipidemic properties as well as the ability to lower raised plasma fibrinogen . The mechanisms of …

    nwu-za Repository record for Die effek van besafibraat en 'n oplosbare nie-styselpolisakkariedsupplement op risikofaktore van koronêre hartvatsiekte in primate (opens in a new tab)

  17. Μηχανισμοί μεταγραφικής ρύθμισης των γονιδίων των απoλιποπρωτεϊνών του ανθρώπου in vivo

    … for oxysterols (LXR), thyroid hormone (TRβ1) and fibrates (PPAR). This element was further characterized by site directed mutagenesis and was found to mediate the response of the apoM promoter to the above agonists. In a region adjacent to this novel HRE, we identified and characterized a dual …

    greece Repository record for Μηχανισμοί μεταγραφικής ρύθμισης των γονιδίων των απoλιποπρωτεϊνών του ανθρώπου in vivo (opens in a new tab)

  18. HDL-structure and function in relation to cardiovascular disease

    … 11% and triglyceride levels by 35%. Although all fibrates have been revealed to raise HDL-C significantly, their overall effect on all-cause mortality and cardiac mortality remains debatable. More recent studies have suggested that the relationship between HDL and cardiovascular risk is more …

    glasgow Download PDF for HDL-structure and function in relation to cardiovascular disease (opens in a new tab)

  19. Μελέτη φλεγμονοδών παραγόντων στο σπλαγχνικό λίπος και στο περιφερικό αίμα σε επίμυες με μεταβολικό σύνδρομο

    Background and Aim: Obesity is the epidemic of the 21st century. The Metabolic Syndrome (MetS) is directly associated with obesity. The MetS is a combination of metabolic abnormalities including abdominal obesity, glucose intolerance, hypertension and dyslipidemia. The prevalence of MetS is …

    greece Repository record for Μελέτη φλεγμονοδών παραγόντων στο σπλαγχνικό λίπος και στο περιφερικό αίμα σε επίμυες με μεταβολικό σύνδρομο (opens in a new tab)

Page 1 of 2